Finding Power in My Panic Attacks
Trouble started in the form of rivulets of sweat dampening the waistband of my underwear. It was a bluebird afternoon in Phoenix in December of 2020, mid 60s, desert dry, and my heart was jackhammering against my ribcage. Breathing felt like I was sucking air through a stir straw. A small ABC News crew was arrayed before me, ready to broadcast the report I’d written that day, but with my vision narrowed to a needle’s eye, I could barely see them. I tried to swallow away the sandiness in my mouth but realized I’d forgotten how.
[time-brightcove not-tgx=”true”]
“I can’t swallow!...
Source: TIME: Health - September 12, 2023 Category: Consumer Health News Authors: Matt Gutman Tags: Uncategorized freelance Source Type: news
Good News Tuesday: Entrada Therapeutics supports initiatives to help those with Duchenne Muscular Dystrophy
Entrada Therapeutics Inc. a biopharmaceutical company aiming to transform the lives of patients through its new class of medicines, has announced recipients of its inaugural Entrada DREAMS Grant Program. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 12, 2023 Category: Pharmaceuticals Source Type: news
The FSHD Society Celebrates Fulcrum's Milestone in the Fight Against FSHD
Fulcrum Therapeutics has announced successful completion of patient enrollment in REACH Phase 3 trial RANDOLPH, Mass., Sept. 8, 2023 /PRNewswire-PRWeb/ -- The FSHD Society, a leading advocate and partner in the quest to find treatments for Facioscapulohumeral Muscular Dystrophy (FSHD), is... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 8, 2023 Category: Pharmaceuticals Tags: TRI Source Type: news
Why Mark Meadows wants an Obama-appointed judge to oversee his Georgia indictment
Mark Meadows and former President Donald Trump. Win McNamee/Getty Images Mark Meadows wants his criminal case moved to federal court, under an Obama-appointed judge. A federal judge may be more sympathetic to arguments that he's immune from the case, experts say. Trump is likely to try the same…#markmeadows #donaldtrump #obama #trump #barackobama #fultoncounty #faniwillis #justicedepartment #jeffreyclark #georgia (Source: Reuters: Health)
Source: Reuters: Health - August 29, 2023 Category: Consumer Health News Source Type: news
European Commission approves Roche ’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1Approval is based on interim data from ongoing RAINBOWFISH trial showing majority ofEvrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months ’ treatment2,3Evrysdi is the only non-invasive SMA therapy and is approved in 100 countries with more than 11,000 patients treated globallyBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved the extension of the Evrysdi ® (risdiplam) European Union (EU) marketing ...
Source: Roche Media News - August 29, 2023 Category: Pharmaceuticals Source Type: news
European Commission approves Roche ’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1Approval is based on interim data from ongoing RAINBOWFISH trial showing majority ofEvrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months ’ treatment2,3Evrysdi is the only non-invasive SMA therapy and is approved in 100 countries with more than 11,000 patients treated globallyBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved the extension of the Evrysdi ® (risdiplam) European Union (EU) marketing ...
Source: Roche Investor Update - August 29, 2023 Category: Pharmaceuticals Source Type: news
Isabel Crook, anthropologist and chronicler of China ’s communist revolution, 1915-2023
A sympathetic westerner who became a participant-observer as the country transformed (Source: Reuters: Health)
Source: Reuters: Health - August 26, 2023 Category: Consumer Health News Source Type: news
Curi Bio lands over $4.4M in NIH grants for two projects
The Seattle-based biotech company is working on projects in Duchenne muscular dystrophy and Botox, which can be used to treat afflictions such as muscle spasms and chronic pain. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 24, 2023 Category: Pharmaceuticals Authors: Rick Morgan Source Type: news
Classic PC Shooter Half-Life 2 Reborn in Lavish Remaster
Half-Life 2, the influential 2004 first-person shooter (FPS) game from Valve, is being remastered with ray tracing technology thanks to a newly formed mod team at Orbifold Studios, PC hardware firm Nvidia announced Tuesday. The team behind the Half-Life 2 RTX remake are recreating game assets and…#halflife2 #fps #orbifoldstudios #nvidia #halflife2rtx #valveshammer #rtxremix #dlss35 #reflex #rtxio (Source: Reuters: Health)
Source: Reuters: Health - August 22, 2023 Category: Consumer Health News Source Type: news
A history of suicide attempt is associated with increased sympathetic activation in bipolar disorder - Ortiz A, Park Y, MacLean S, Husain MI, Sanches M, Ravindran A, Mulsant BH.
OBJECTIVE: Suicide risk in bipolar disorder (BD) is estimated to be up to 20 times higher than in the general population. While there is a large body of evidence suggesting that increased sympathetic activation is associated with disease and death, there i... (Source: SafetyLit)
Source: SafetyLit - August 21, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Donald Trump is likely to push for the Georgia charges against him to be heard in federal court, which could delay the proceeding
Donald Trump is likely to push for the Georgia charges against him to be heard in federal court, a tactic that could delay the proceeding and, if successful, give the former president a potentially more sympathetic jury.#donaldtrump #georgia (Source: Reuters: Health)
Source: Reuters: Health - August 19, 2023 Category: Consumer Health News Source Type: news
Donald Trump Is Likely to Try to Move Georgia Case to Federal Court. It Could Work
Donald Trump is likely to push for the Georgia charges against him to be heard in federal court, a tactic that could delay the proceeding and, if successful, give the former president a potentially more sympathetic jury.#donaldtrump #georgia (Source: Reuters: Health)
Source: Reuters: Health - August 18, 2023 Category: Consumer Health News Source Type: news
FDA-approved gene therapy invented at Nationwide Children's carries a $3.2M price tag. Here's why.
On Wednesday, a 5-year-old boy in Washington, D.C., received the first infusion with FDA-approved Elevidys, a gene therapy invented at Nationwide Children's Hospital for Duchenne muscular dystrophy, which usually kills by age 30. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 4, 2023 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news
FibroGen limits rare-disease drug's access after clinical trial failure. Some parents say it was saving their kids' lives
'How long before my heart fails?' Tanner Edwards asked his mom after losing access to a FibroGen drug he's taken for six years for Duchenne muscular dystrophy. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2023 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both divisions ’ base business; Group sales and profit reflect declining demand for COVID-19 products
Excluding COVID-19 products,Groupsales increase strongly by 8%1at constant exchange rates (CER)In line with the expected declining demand for COVID-19 products,Groupsales decrease 2% (-8% in Swiss francs)Pharmaceuticals Division sales grow strongly by 8% due to continued high demand for newer medicines; new eye medicine Vabysmo is the strongest growth driverDiagnostics Division ’s base businesscontinues its good growth momentum with an increase of 6%, while total divisional sales are 23% lower due to exceptionally high demand for COVID-19 tests in the first half of 2022Core earnings per share decrease 5%, driven by lower...
Source: Roche Investor Update - July 27, 2023 Category: Pharmaceuticals Source Type: news
